These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32034015)

  • 1. Multicentre randomised controlled trial of balloon pulmonary angioplasty and riociguat in patients with chronic thromboembolic pulmonary hypertension: protocol for the MR BPA study.
    Kawakami T; Matsubara H; Abe K; Kataoka M; Kohsaka S; Sato Y; Shinke T; Fukuda K
    BMJ Open; 2020 Feb; 10(2):e028831. PubMed ID: 32034015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for a multicentre, double-blind, randomised, placebo-controlled trial of riociguat on peak cardiac index during exercise in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty (THERAPY-HYBRID-BPA trial).
    Shimokawahara H; Inami T; Kubota K; Taniguchi Y; Hashimoto H; Saito AM; Sekimizu M; Matsubara H
    BMJ Open; 2023 Jul; 13(7):e072241. PubMed ID: 37407055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA): an open-label, randomised controlled trial.
    Kawakami T; Matsubara H; Shinke T; Abe K; Kohsaka S; Hosokawa K; Taniguchi Y; Shimokawahara H; Yamada Y; Kataoka M; Ogawa A; Murata M; Jinzaki M; Hirata K; Tsutsui H; Sato Y; Fukuda K
    Lancet Respir Med; 2022 Oct; 10(10):949-960. PubMed ID: 35926544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balloon pulmonary angioplasty combined with riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (PRACTICE study): study protocol for a randomized controlled trial.
    Zhao QH; Gong SG; He J; Yuan P; Wu WH; Luo CJ; Jiang R; Zhang R; Qiu HL; Li HT; Li Y; Liu JM; Wang L
    Trials; 2021 Dec; 22(1):957. PubMed ID: 34961562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study.
    Jaïs X; Brenot P; Bouvaist H; Jevnikar M; Canuet M; Chabanne C; Chaouat A; Cottin V; De Groote P; Favrolt N; Horeau-Langlard D; Magro P; Savale L; Prévot G; Renard S; Sitbon O; Parent F; Trésorier R; Tromeur C; Piedvache C; Grimaldi L; Fadel E; Montani D; Humbert M; Simonneau G
    Lancet Respir Med; 2022 Oct; 10(10):961-971. PubMed ID: 35926542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    Ikeda N
    Cardiovasc Interv Ther; 2020 Apr; 35(2):130-141. PubMed ID: 31873853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balloon pulmonary angioplasty vs riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.
    Wang W; Wen L; Song Z; Shi W; Wang K; Huang W
    Clin Cardiol; 2019 Aug; 42(8):741-752. PubMed ID: 31188483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
    Kim NH; D'Armini AM; Grimminger F; Grünig E; Hoeper MM; Jansa P; Mayer E; Neurohr C; Simonneau G; Torbicki A; Wang C; Fritsch A; Davie N; Ghofrani HA
    Heart; 2017 Apr; 103(8):599-606. PubMed ID: 28011757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in the diagnosis and management of chronic thromboembolic pulmonary hypertension.
    Tanabe N; Sugiura T; Tatsumi K
    Respir Investig; 2013 Sep; 51(3):134-46. PubMed ID: 23978639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.
    Ghofrani HA; Gomez Sanchez MA; Humbert M; Pittrow D; Simonneau G; Gall H; Grünig E; Klose H; Halank M; Langleben D; Snijder RJ; Escribano Subias P; Mielniczuk LM; Lange TJ; Vachiéry JL; Wirtz H; Helmersen DS; Tsangaris I; Barberá JA; Pepke-Zaba J; Boonstra A; Rosenkranz S; Ulrich S; Steringer-Mascherbauer R; Delcroix M; Jansa P; Šimková I; Giannakoulas G; Klotsche J; Williams E; Meier C; Hoeper MM;
    Respir Med; 2021 Mar; 178():106220. PubMed ID: 33540340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in targeted therapy for chronic thromboembolic pulmonary hypertension.
    Zhang Y; Yu X; Jin Q; Luo Q; Zhao Z; Zhao Q; Yan L; Liu Z
    Heart Fail Rev; 2019 Nov; 24(6):949-965. PubMed ID: 31044326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Chronic Thromboembolic Pulmonary Hypertension: The Role of Medical Therapy and Balloon Pulmonary Angioplasty.
    Fernandes TM; Poch DS; Auger WR
    Methodist Debakey Cardiovasc J; 2016; 12(4):205-212. PubMed ID: 28289495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension.
    Wiedenroth CB; Rolf A; Steinhaus K; Adameit MSD; Kriechbaum SD; Haas M; Roller F; Hamm CW; Ghofrani HA; Mayer E; Breithecker A; Guth S; Liebetrau C
    J Heart Lung Transplant; 2023 Jan; 42(1):134-139. PubMed ID: 36257870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical Therapy Versus Balloon Angioplasty for CTEPH: A Systematic Review and Meta-Analysis.
    Phan K; Jo HE; Xu J; Lau EM
    Heart Lung Circ; 2018 Jan; 27(1):89-98. PubMed ID: 28291667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Balloon Pulmonary Angioplasty and Pulmonary Vasodilators for Inoperable Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Meta-Analysis.
    Kalra R; Duval S; Thenappan T; Raveendran G; Pritzker M; Prisco SZ; Prins KW
    Sci Rep; 2020 Jun; 10(1):8870. PubMed ID: 32483219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically Worsening Chronic Thromboembolic Pulmonary Hypertension by Riociguat After Balloon Pulmonary Angioplasty.
    Minatsuki S; Hatano M; Kiyosue A; Saito A; Maki H; Takimoto E; Komuro I
    Int Heart J; 2018 Sep; 59(5):1186-1188. PubMed ID: 30158388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of riociguat in the treatment of chronic thromboembolic pulmonary arterial hypertension: A meta-analysis.
    Ying M; Song J; Gu S; Zhao R; Li M
    Medicine (Baltimore); 2021 Jun; 100(22):e26211. PubMed ID: 34087896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Marra AM; Egenlauf B; Ehlken N; Fischer C; Eichstaedt C; Nagel C; Bossone E; Cittadini A; Halank M; Gall H; Olsson KM; Lange TJ; Grünig E
    Int J Cardiol; 2015 Sep; 195():19-26. PubMed ID: 26011408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension?
    Kim NH
    Eur Respir Rev; 2010 Mar; 19(115):68-71. PubMed ID: 20956169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study.
    McLaughlin VV; Jansa P; Nielsen-Kudsk JE; Halank M; Simonneau G; Grünig E; Ulrich S; Rosenkranz S; Gómez Sánchez MA; Pulido T; Pepke-Zaba J; Barberá JA; Hoeper MM; Vachiéry JL; Lang I; Carvalho F; Meier C; Mueller K; Nikkho S; D'Armini AM
    BMC Pulm Med; 2017 Dec; 17(1):216. PubMed ID: 29282032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.